Stromedix stromedix.com


Public lists: Smart Money VCs (6328)

Stromedix is a development stage biotechnology company focused on therapies for fibrosis. In February 2012, Stromedix was acquired by Biogen Idec. The valuation of Stromedix was $562.5 million.

Stromedix is a development stage biotechnology company focused on therapies for fibrosis. In February 2012, Stromedix was acquired by Biogen Idec. The valuation of Stromedix was $562.5 million.

Company (Acquired)

Phone:

Fax:

One Canal Park
Suite 1120
Cambridge, 02141
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Stromedix $28M Feb 14, 2012
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Stromedix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Bessemer Venture PartnersVenture CapitalRedwood City, California, United StatesSeries B
Atlas VentureVenture CapitalCambridge, Massachusetts, United StatesSeries B, Series A
Frazier HealthcarePrivate EquitySeattle, Washington, United StatesSeries B, Series A
New Leaf Venture PartnersVenture CapitalNew York, New York, United StatesSeries B
Red Abbey Venture PartnersCorporate VentureBaltimore, Maryland, United StatesSeries B
See all 6 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)